Drugs News and Research

RSS

EuroTech Universities Alliance to highlight innovations in communication/education at ESOF 2014

The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.

18 Jun 2014

U-M researchers detail new discoveries about basic biology of dystonia

Twist and hold your neck to the left. Now down, and over to the right, until it hurts. Now imagine your neck - or arms or legs - randomly doing that on their own, without you controlling it.

18 Jun 2014

A new approach to treating whipworm infections

Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries.

18 Jun 2014

Researchers find sharp increase in deaths from commonly prescribed painkillers in US, Canada

The number of deaths involving commonly prescribed painkillers is higher than the number of deaths by overdose from heroin and cocaine combined, according to researchers at McGill University.

18 Jun 2014

Scottsdale Healthcare, TGen initiate AG-120 clinical trial in patients with solid tumors

The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, especially those with brain tumors and gallbladder bile duct cancer.

18 Jun 2014

Single dose restores normal cellular signaling in mouse model of autism

In a further test of a novel theory that suggests autism is the consequence of abnormal cell communication, researchers at the University of California, San Diego School of Medicine report that an almost century-old drug approved for treating sleeping sickness also restores normal cellular signaling in a mouse model of autism, reversing symptoms of the neurological disorder in animals that were the human biological age equivalent of 30 years old.

18 Jun 2014

OHS performs clinical drug trial to reduce cholesterol levels with just one injection

Research One, Inc., an affiliate of Orlando Heart Specialists (OHS), is seeking candidates for a clinical drug trial that could reduce cholesterol levels with just one injection, twice a month.

17 Jun 2014

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

17 Jun 2014

Viewpoints: Could Congress sue Obama?; abortion coverage for Peace Corps volunteers

President Obama is setting a dangerous precedent by suspending his enforcement of laws on health care, immigration, drugs, banking and so much else, but the courts may soon be asked to throw a brushback pitch. .

17 Jun 2014

Parents value convenience of sports physicals but recognize importance of thorough doctor visits

Nearly half of parents say any qualified health care provider - not just a child's usual provider - can do a sports physical, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

17 Jun 2014

Houston clinic finds ways to limit drug industry influence

Doctors are becoming wary of the appearance that drug makers' gifts can influence their prescription choices. Meanwhile, the federal government serves notice that it wants to find a way to preserve a regulation that would allow hospitals to get discounts on orphan drugs.

17 Jun 2014

Provepharm, DFKC partner to launch Methylthioninium chloride Proveblue in Germany

Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm’s drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.

17 Jun 2014

Artificial sweetener have potential to limit impact of therapeutic drugs

One of the active ingredients in a popular artificial sweetener could have the potential to limit the impact of therapeutic drugs, reduce the number and balance of beneficial bacteria in the gut and alter hormone secretion, according to an article published in Journal of Toxicology and Environmental Health, Part A: Current Issues.

17 Jun 2014

International researchers discover genetic component of Idiopathic Generalized Epilepsy

An international team of researchers has discovered a significant genetic component of Idiopathic Generalized Epilepsy (IGE), the most common form of epilepsy.

17 Jun 2014

Combination of effective drugs for Parkinson's disease controls symptoms of Rett syndrome in mice

IDIBELL researchers, led by the director of the Program for Epigenetics and Cancer Biology, ICREA researcher and Professor of Genetics at the University of Barcelona, Manel Esteller, have shown that a combination of effective drugs for Parkinson's disease in mice that are used as a model of human Rett syndrome reduces some of the symptoms associated with this disease.

17 Jun 2014

Survival differences after docetaxel, erlotinib are EGFR dependent

Results from the DELTA trial indicate no significant differences in progression-free or overall survival after treatment with docetaxel versus erlotinib in non-small-cell lung cancer patients unselected for their epidermal growth factor receptor mutation status.

16 Jun 2014

Arrowhead Research joins with broad-market Russell 3000 Index

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, is set to join the broad-market Russell 3000 Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes.

16 Jun 2014

Investigators study new cancer immunotherapy to help patients with advanced pancreatic cancer

Medical investigators at the Virginia G. Piper Cancer Center at Scottsdale Healthcare are studying a new cancer immunotherapy to see if it can successfully help patients with advanced pancreatic cancer.

16 Jun 2014

Research roundup: Hospital readmissions; researchers mistrust social media; premiums in Washington state

Reducing hospital readmissions is a major target for current quality improvement and cost-containment efforts.

16 Jun 2014

FDA approves use for Lymphoseek to help doctors determine extent of neck and cancer

The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.

16 Jun 2014

Drugs News and Research

EuroTech Universities Alliance to highlight innovations in communication/education at ESOF 2014

U-M researchers detail new discoveries about basic biology of dystonia

A new approach to treating whipworm infections

Researchers find sharp increase in deaths from commonly prescribed painkillers in US, Canada

Scottsdale Healthcare, TGen initiate AG-120 clinical trial in patients with solid tumors

Single dose restores normal cellular signaling in mouse model of autism

OHS performs clinical drug trial to reduce cholesterol levels with just one injection

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Viewpoints: Could Congress sue Obama?; abortion coverage for Peace Corps volunteers

Parents value convenience of sports physicals but recognize importance of thorough doctor visits

Houston clinic finds ways to limit drug industry influence

Provepharm, DFKC partner to launch Methylthioninium chloride Proveblue in Germany

Artificial sweetener have potential to limit impact of therapeutic drugs

International researchers discover genetic component of Idiopathic Generalized Epilepsy

Combination of effective drugs for Parkinson's disease controls symptoms of Rett syndrome in mice

Survival differences after docetaxel, erlotinib are EGFR dependent

Arrowhead Research joins with broad-market Russell 3000 Index

Investigators study new cancer immunotherapy to help patients with advanced pancreatic cancer

Research roundup: Hospital readmissions; researchers mistrust social media; premiums in Washington state

FDA approves use for Lymphoseek to help doctors determine extent of neck and cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News